<DOC>
	<DOC>NCT02419027</DOC>
	<brief_summary>A Multi-center, Randomized, Double-blinded, Placebo-controlled Human Study to Evaluate the Efficacy and Safety of probiotic mixture(®GI Flora) in Subjects with Irritable Bowel Syndrome. Regimen: 6 probiotics mixture &gt;10^9/D for 8 weeks Primary variable: visual analogue scale(VAS) assessment for abdominal pain Secondary variable: 1. change of VAS score for abdominal pain/discomfort after 4/8-week treatment 2. daily symptom score for bloating, defecation discomfort(strain/urgency/incomplete evacuation), flatulence , feces shape, frequency of bowel movements</brief_summary>
	<brief_title>A Multi-center Human Study to Evaluate the Efficacy and Safety of ®GI Flora in Subjects With Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Irritable bowel syndrome patients according to Rome III criteria Recurrent abdominal pain or discomfort for at least 3 days per month in the last 3 months associated with at least 2 of the following characteristics: a) improvement with defecation; b) onset associated with a change in the frequency of stool; c) onset associated with a change in form (appearance) of stool. Intolerable or hypersensitive to GI Flora. Patients with active colon diverticulitis. History of GI surgeries except hernia repair, appendectomy, primary closure due to perforation. History of inflammatory bowel disease, malignancy requiring surgery or chemotherapy or radiation within 5 years. Patient has any condition that, in the opinion of the Investigator, would compromise the wellbeing of the patient or the requirements of the study.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>GI Flora</keyword>
</DOC>